Bovine Colostrum for Prophylaxis Against Recurrent Urinary Tract Infection in Children
Status:
Recruiting
Trial end date:
2024-03-01
Target enrollment:
Participant gender:
Summary
Prebiotics as bovine colostrum are considered as a valuable supplement in the prevention of
upper respiratory tract infections, gastrointestinal tract infections and neonatal sepsis. It
contains many bioactive substances, such as immunoglobulins, lactoferrin, lysozyme,
lactoperoxidase, and other growth factors.There is a lack of research on the use of
prebiotics for prophylaxis against recurrent urinary tract infection (UTI) in children.In
this era of increasing bacterial resistance to antimicrobial therapy, bovine colostrum can
offer an approach for prophylaxis against UTI in these patients.We aim at this trial to
evaluate the efficacy and safety of bovine colostrum as a prebiotic for prophylaxis against
recurrent urinary tract infection in children.